Dr. Reddy's Laboratories Ltd. (RDY)

36.25
0.82 2.21
NYSE : Health Technology
Prev Close 37.07
Open 36.72
Day Low/High 36.25 / 36.91
52 Wk Low/High 29.00 / 42.82
Volume 137.12K
Avg Volume 163.00K
Exchange NYSE
Shares Outstanding 166.01M
Market Cap 6.10B
EPS 1.60
P/E Ratio 22.60
Div & Yield 0.29 (0.74%)
Dr. Reddy's To Release Q3 FY18 Results On January 25, 2018

Dr. Reddy's To Release Q3 FY18 Results On January 25, 2018

Dr. Reddy's Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the Third Quarter ended December 31, 2017 on Thursday, January 25, 2018 after the Board Meeting.

Dr. Reddy's Laboratories Limited To Present At The 36th Annual J.P. Morgan Healthcare Conference

Dr. Reddy's Laboratories Limited To Present At The 36th Annual J.P. Morgan Healthcare Conference

Dr. Reddy's Laboratories Ltd (BSE: 500124)(NSE: DRREDDY)(NYSE: RDY) announced that the Company will be presenting at the 36th Annual J.

Dr. Reddy's Laboratories Announces The Launch Of Melphalan Hydrochloride For Injection In The U.S. Market

Dr. Reddy's Laboratories Announces The Launch Of Melphalan Hydrochloride For Injection In The U.S. Market

Dr. Reddy's Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran® (melphalan...

Drug Companies Respond to States Generic Drug Lawsuit

Drug Companies Respond to States Generic Drug Lawsuit

State attorneys general led by Connecticut's George Jepsen said Tuesday that were planning to include Mylan president Rajiv Malik and Emcure Pharmaceuticals Ltd. executive Satish Mehta in an expanded complaint in the federal generic drug antitrust lawsuit.

Dr. Reddy's Q2 And H1 FY18 Financial Results

Dr. Reddy's Q2 And H1 FY18 Financial Results

Dr. Reddy's Laboratories Ltd.

DR. REDDY'S 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors Of Deadline In Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)

DR. REDDY'S 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors Of Deadline In Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against Dr.

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of October 24th Lead Plaintiff Deadline In Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of October 24th Lead Plaintiff Deadline In Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that October 24 th is the deadline for lead plaintiff motions in the securities class...

DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm

DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr.

Dr. Reddy's To Release Q2 FY18 Results On October 31, 2017

Dr. Reddy's To Release Q2 FY18 Results On October 31, 2017

Dr. Reddy's Laboratories (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) will announce results for the Second Quarter ended September 30, 2017 on Tuesday, October 31, 2017 after the Board Meeting.

DR. REDDY'S SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)

DR. REDDY'S SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Dr. Reddy's Laboratories Ltd. - (RDY)

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 24, 2017 to file lead plaintiff applications in a securities class action lawsuit against Dr.

DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm

DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Dr. Reddy's Laboratories Limited To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy's Laboratories Ltd. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy's Laboratories Ltd. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of October 24th Lead Plaintiff Deadline In Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of October 24th Lead Plaintiff Deadline In Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that a securities class action has been filed against Dr.

The Klein Law Firm Reminds Investors Of Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm Reminds Investors Of Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr.

RDY EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

RDY EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr.

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr.

The Klein Law Firm Announces Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm Announces Commencement Of A Class Action Filed On Behalf Of Dr. Reddy's Laboratories Ltd. Shareholders And A Lead Plaintiff Deadline Of October 24, 2017

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Dr.

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene, A Wholly Owned Subsidiary Of Dr. Reddy's, And Curis Announce CA-170 Program Update Following Data Presented At ESMO 2017

Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr.

RDY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

RDY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Dr. Reddy's Laboratories Ltd. And A Lead Plaintiff Deadline Of October 24, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Dr.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy's Laboratories Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Dr. Reddy's Laboratories Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Dr. Reddy's Laboratories Ltd. Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 24, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dr.

TheStreet Quant Rating: C (Hold)